Mohammad is a Ph.D student at the National Center for Nanoscience and Technology, China. He received his B.S. degree from Shahid Beheshti University in 2015, followed by an M.S. degree from University of Chinese Academy of Sciences (NCNST) in 2017. In 2017, he accepted in Ph.D qualification exam from NCNST, Chinese Academy of Sciences. He was ranked in the upper 5 % among around 500,000 participants in the nationwide undergraduate entrance exam of universities in Iran 2011. He has been research member at two bilateral project and symposium between Chinese Academy of Sciences and Vice Presidensy for science and technology of Iran. His main interests are design of bio-inspired materials to overcome the barriers in tumor therapy and nanobiomedicine. He would like to working toward the controlling the chemical properties of multi-functional nanoparticles in order to allow specific targeting and regulation of tumor cells and their microenvironment.
Targeting and regulation of tumors and their microenvironment mediated by intelligent functional nanomaterials for diagnostic and therapeutic applications, especially Breast cancers.
Dr. Xiaoshan “Shirley” Shi is a Microbiologist and Immunologist with strong background in tumor immunology and host-pathogen interactions. She acquired her doctorate degree in Microbiology from New York University Medical Center, where she studied the mechanism of the copper homeostasis in Mycobacterium tuberculosis (Mtb). To expand her knowledge in Immunology, she did her postdoctoral training in Cedars-Sinai Medical Center, where she studied the immune response to both cancer development and infections. Dr. Shi is currently working for department of Immuno-Oncology, MedGenome Inc, US. She is setting up dendritic cell-T cell co-culture assays to screen patient tumor-derived peptides for cancer vaccines. Using a variety of molecular, cellular and bioinformatical approaches, she is trying to understand how the cancer vaccines stimulate the immune system to control tumor development in patients.
Bacteria pathogenesis, tumor immunology, microbiome, host-pathogen interactions, cancer vaccine, immunotherapy.
I am a MD, PhD, Internist and Geriatrician, currently working as a post-doctoral fellow at the Center for Clinical and Epidemiological Research - Hospital Universitário, at University of São Paulo (Brazil).
My research interests are Geriatrics, sarcopenia, frailty, and adverse events.
Department of Bio-Process and Analytical Development
Aura Biosciences, USA
Ilias was born in Drama, Greece, in 1994. He obtained his first degree on Molecular Biology & Genetics at Democritus University of Thrace, studying for his final year thesis with Associate Prof. Aglaia Pappa on the cytoprotective actions of propolis enriched formulations. Being excited and charmed by the research work, he is now a PhD student, investigating the role of aldehyde dehydrogenases in cancer stem-like cells with Associate Prof. Aglaia Pappa at the Department of Molecular Biology & Genetics, Democritus University of Thrace (Alexandroupoli, Greece). His doctoral studies are funded by the Bodossaki Foundation (Athens, Greece).
Dr. Xin Li is a proficient medicinal and synthetic organic chemist in the drug development of antibacterial, anticancer and antipsychotic research area. Expertise in drug design, chemical synthesis, chemical separation, structure characterization and purity analysis. Knowledgeable in the evaluation of antibacterial agents and enzyme experiments.
Discovery and development of novel agents for the treatment of intractable human diseases.
Dr. Lucas Possebon is a biologist, and he had specialized in the area of histology and cell biology. He had a great knowledge in genetics and molecular biology. The research line that he had developed is in lung, more specific for lung diseases (COPD, pulmonary emphysema, chronic bronchitis, ...), medicinal plants in their anti-inflammatory aspects and also study drugs in treatment of inflammatory processes with observations of signaling pathways.
I got my doctoral degree in medicinal chemistry at Shanghai Institute of Materia Mdedica, Chinese Academy of Sciences, in China in 2013. After graduation, I got a job as an assistant professor in Shanghai Institute of Pharmaceutical Industry until April 2015. Afterwards, I got a postdoctoral position to continue research on drug metabolism and metabolomics at the University of Pittsburgh.
Medicinal chemistry; Drug design; SAR study; synthetic methodology of heterocycles and structural modification of natural products; Drug metabolism and pharmacokinetics.
Dr. Haichang Xin has developed research interests and expertise in health services research, health economics and outcomes, and health policies. Dr. Xin has conducted health services research using econometrics modeling with large scale data sets. His publications focus on areas that aim to improve efficiency and effectiveness in healthcare systems. These areas include 1. Benefit structure designs in health insurance 2. Innovative healthcare organization and delivery models 3. Preventable hospital admissions and readmissions 4. Nonurgent emergency department care use and costs 5. Health disparities in cancer Currently, Dr. Xin has had a number of publications (most first-author papers) in academic journals, has had multiple oral presentations and moderations in international professional conferences, and has reviewed 100 papers for a number of prestigious academic journals and conferences. Dr. Xin has served as the editor for multiple journals, such as Journal of Public Health.
Benefit structure designs in health insurance, Innovative healthcare organization and delivery models, Preventable hospital admissions and readmissions, Nonurgent emergency department care use and costs, Health disparities in cancer.
Dr. Santanu De is an Assistant Professor of Anatomy and Physiology in the Department of Biological Sciences at Nova Southeastern University, Fort Lauderdale, FL. He received a Ph.D. in Physiology from Kent State University, OH and has pursued Postdoctoral positions at Purdue University, IN and at a collaboration of Yale University with the National University of Singapore. He was also a full-time Visiting Faculty in the Biomedical Sciences at Grand Valley State University, MI. He has published several peer-reviewed papers and presented at multiple meetings.
He has taught many courses and has a diverse range of research interests broadly including but not limited to: reproductive physiology, reproductive medicine, female infertility, cell biology, protein expressions and interactions, STEM education, pedagogy and related areas.
Ms. Nirali Rathwa is a Ph.D. Scholar (Biochemistry) from The Maharaja Sayajirao University of Baroda, Vadodara, India with more than 5 years of experience. She holds a dual masters’ degree specialized in Biochemistry (The Maharaja Sayajirao University of Baroda, Vadodara, India) and Biotechnology (Hemchandracharya North University, Patan, India). Her research includes an association study of genetic variants of adipokines towards the risk of type 2 diabetes in the western Indian population employing molecular biology techniques i.e DNA/RNA extraction, PCR, ELISA, statistical analysis. She has also assessed the natural molecules as the potential beta-cell regenerative therapeutants through murine experiments, ELISA, IHC, confocal microscopy, and western-blot. She has attended several international conferences and published 7 scientific articles.
Ms. Rathwa’s area of interest is Diabetes Mellitus. It is focused on the association studies of genetic variants of adipokines in towards risk of Type 2 diabetes and screening of potential beta-cell regenerative therapeutants.
Dr. Darko Medin is a Biostatistics and data analysis expert. Graduated as a Master of Experimental biology and Biotechnology at the University of Montenegro. Biology Professor, coauthor and researcher in various biology fields (Diabetes, Stem cells, Anthropology and IVF Biostatistics). Innovation and Entrepreneurship Center Tehnopolis project assistant.
Experimental biology and Biotechnology, Biostatistics and Data Analysis.
Cincinnati Children's Hospital Medical Center, USA
Mansi Babbar received her bachelor’s degree of engineering with honors in biotechnology from Kurukshetra University, India in 2010. She then moved to SUNY Upstate Medical University, New York for her PhD degree. She did her PhD study in the laboratory of Dr M. Saeed Sheikh. Her thesis projects were focused on characterization of novel mitochondrial proteins as cancer biomarkers and their role in cancer metabolism. She identified various tumor marker involved in regulating mitochondrial and metabolic activity. She was awarded her doctorate degree in 2017. Afterwards, she joined the Dr. Vilhelm Bohr’s Laboratory at NIH. Her current project focuses on the influence of altered metabolism and insulin signaling in normal aging and age-related disorders like Werner Syndrome, Cockayne Syndrome and Alzheimer’s disease. Alterations in glucose and lipid metabolism are associated with enhanced mitochondrial defects and aging. This research project will provide potential targeting avenues in age-related metabolic disorders.